Niagen Bioscience (NAGE) Capital Expenditures Growth (3y) (2016 - 2020)
Niagen Bioscience (NAGE) Capital Expenditures Growth (3y) (2016 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 16.27% |
| 10 | Niagen Bioscience | 258.93 Mn | 192.38 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -11.56% |
| Mar 31, 2020 | -54.76% |
| Dec 31, 2019 | -20.82% |
| Sep 30, 2019 | -39.78% |
| Jun 30, 2019 | -31.49% |
| Mar 31, 2019 | 143.13% |
| Dec 31, 2018 | -72.33% |
| Apr 2, 2016 | 30.82% |
| Jan 2, 2016 | 252.29% |